Safekipedia

Gliogenesis

Adventurer · ages 7–10Adapted from Wikipedia
A diagram showing how neural stem cells develop into either neurons or glial cells, with signaling molecules guiding the process.

Gliogenesis is the process that creates glia, which are cells that are not neurons.

These glia cells come from multipotent neural stem cells. Stem cells can grow into several different kinds of cells.

So gliogenesis is how a group of glia cells forms from these stem cells.

Overview

Gliogenesis is the process that forms glia, which are non-neuronal cells, from neuronal cells. Glial cells help the central nervous system (CNS) and the peripheral nervous system in many ways. Later differentiation creates different groups of glial cells, and each group has a special job. Glial-derived astrocytes help keep the chemical balance around nerve cells by changing ion gradients and neurotransmitter signals. Oligodendrocytes make myelin, which wraps around axons and helps electrical signals travel quickly. Microglial cells come from glial precursors and act a bit like macrophage cells, cleaning up broken cell pieces and foreign material in the CNS.

Signals inside and around cells turn gliogenesis and glial differentiation on. Other signals control when these processes slow down. Scientists understand this process better in the CNS, so this section focuses on that system. Learning how these processes are controlled could help scientists guide what glial cells become, which might help in treating neurodegenerative diseases.

Gliogenesis induction

After neural stem cells form, they can follow one of three paths. They can become new neurons through neurogenesis in the central nervous system, they can switch to gliogenesis, or they can stay in a pluripotent state. The rules that guide these choices are similar in invertebrate and vertebrate animals. Nearby cells send signals that help steer them. Much early research used invertebrates. This research showed scientists certain signaling molecules and pathways that decide whether a stem cell stays a stem cell or changes.

Stem cell differentiation and Notch-Delta lateral inhibition in neural stem cells, resulting in the generation of neuronal and glia progenitors.

Scientists know that Notch signaling drives many of the events that lead to gliogenesis. Notch family proteins are transmembrane receptors that are switched on by a ligand. When this happens, part of the receptor moves into the nucleus. There it helps switch on transcription factors that support gliogenesis. These factors attach to promoters of genes that make glial cells. At the same time, Notch turns down many genes needed for neuron development. In some central nervous system tissues, JAK/STAT signaling also helps promote gliogenesis. The level of ciliary neurotrophic factor (CNTF) rises just before this process begins. These receptors are often activated when Delta or Jagged binds to them.

Gliogenesis regulation

Gliogenesis is carefully controlled. This makes sure glial cells form at the right time and in the right amounts. When glial cells should not form, or when neurons are needed, cells make large amounts of proneural factors. These proteins block many of the signals that start gliogenesis. The receptors that carry these signals also change, which stops the signals from spreading. When neurons are needed, neurogenic factors such as BMPs turn on proneural proteins like Neurogenin and ASCL1. These proteins move a group of molecules from Notch signaling away from the genes that make glia and toward the genes that make neurons. Neural stem cells also respond less to growth factors as they develop. Notch receptors need about 50 times more signal molecules to start the same response that earlier stem cells needed. This helps stop further specialization after the early stages of development.

Cells can also control gliogenesis by pulling receptors inside through endocytosis from the plasma membrane. When gliogenesis is turned off, cells make more of the Notch-binding protein Numb. Numb either connects the Notch receptor to packages that carry it back to the cell surface, or it brings in ubiquitin ligases. These tag Notch so that it ubiquitinates and breaks down. In both cases, Notch does not reach the nucleus, so the molecules needed to make glial cells are not produced.

Gliogenic-associated pathology

Recent research has shown that problems in the signals that control gliogenesis (the making of glial cells) and neurogenesis (the making of nerve cells) may play a part in the pathogenesis of brain diseases that slowly damage nerve cells. These problems may also play a part in tumor growth in the nervous system. Learning how neural stem cells choose what to become helps scientists find ways to affect how these diseases develop. The pathology of these brain diseases is linked to problems in these gliogenic pathways. The subventricular zone (SVZ) of the forebrain is especially important because it holds the largest supply of neural stem cells in the brain. In people with multiple sclerosis (MS), damaged areas are often seen in this region, and they often extend toward the lateral ventricles of the brain. Immune cells move into the gliogenic areas near these damaged spots and start an inflammatory response. It is thought that cytokine release during this response reduces the neural stem cells and their ability to become glial cells. This means fewer oligodendrocytes are made, which makes it harder to keep up myelin, the coating that protects nerve fibers and is a key feature of MS. Scientists are also studying gliogenesis problems in Huntington's, Parkinson's, and Alzheimer's diseases. Strong evidence shows a process similar to MS.

When glial cell production is not controlled, tumors can form, including glioma in the central nervous system. Gliomas lose contact inhibition, which normally stops cells from crowding each other. They also lose control over cellular migration, meaning how cells move, and their growth is no longer regulated. These malignant features most often come from changes in genes, such as chromosome deletions, translocations, and point mutations. In healthy neural stem cells, natural controls keep growth in check, but damage to genes can break these controls. Studies suggest a glioma may form when cells stop responding to growth factors and signals, such as neurogenin, that would normally stop glial cells from dividing. Changes in receptor proteins are thought to leave these cells dividing constantly.

Therapeutic intervention of gliogenic-derived pathogenesis

Scientists need to understand how glial cells are made and how that process is switched on and off. This helps them find ways to treat diseases of the nervous system. One idea being studied is cell replacement, which means putting new cells into the body. It might help with brain disorders involving glial cells and with glial tumors. For this to work, the new cells must be made in large enough numbers, must be accepted by the body's immune system, and must be able to keep growing. Research in the past ten years has offered new ideas for these problems. Scientists can change mature nerve cells back into neural stem cells. These stem cells can then be guided into the types of cells lost in some diseases, such as oligodendrocytes in people with MS or astrocytes in people with Alzheimer's, when the right signals are present.

Signals that control how glial cells grow may also become targets for treatment. This could help with brain cancers that start in glial cells and with other cancers of the central nervous system. In medulloblastomas, scientists have started testing treatments in living animals. They block Notch receptors with special inhibitors to stop the cancer cells from developing further. These inhibitors made the medulloblastoma cells much more sensitive to apoptotic induction. Learning how gliogenesis is controlled gives new direction for treating disorders of the nervous system.

Quiz time!

4 questions about Gliogenesis

Question 1 of 4

What is gliogenesis?

Keep exploring

This article is a child-friendly adaptation of the Wikipedia article on Gliogenesis, available under CC BY-SA 4.0.

Images from Wikimedia Commons. Tap any image to view credits and license.